Compare ADMA Biologics Inc (ADMA) vs Diageo plc (DEO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Diageo plc — how do they compare? ADMA Biologics Inc trades at $9.87 (market cap $2.22B), while Diageo plc trades at $93.67 (market cap $53.05B). The key difference: Diageo plc is far larger — about 23.9× ADMA Biologics Inc's market cap, and Diageo plc pays a 3.5% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | DEO | |
|---|---|---|
Market Cap | $2.22B | $53.05B |
Sector | Health | Technology |
52-Week High | $20.38 | $115.33 |
52-Week Low | $7.60 | $72.47 |
Enterprise Value | $2.29B | $72.54B |
Dividend Yield | — | 3.5% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Diageo plc
Diageo is a global leader in beverage alcohol with an outstanding collection of brands including Johnnie Walker, Smirnoff, and Guinness. It operates a vast portfolio of spirits and beers across more than 180 countries.
Read more on DEO →
